CAR NK cell production from human cord blood NK progenitor cells is enhanced by stimulation of the IL-15 receptor
Cancer Immunology, Immunotherapy · 2025
DOI: 10.1007/s00262-025-04191-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2025. Verfasst von Yosuke Kogue und 13 weiteren Autor:innen. Beteiligte Einrichtung: Osaka Research Center for Drug Discovery, Otsuka Pharmaceutical Company, Ltd., Minoh, Osaka, 562-0029, Japan. Hauptthemen laut MEDLINE: Killer Cells, Natural, Fetal Blood, Receptors, Chimeric Antigen, Immunotherapy, Adoptive. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Cord blood (CB)-derived chimeric antigen receptor (CAR) natural killer (NK) cells have demonstrated significant antitumor efficacy. We recently reported that CB-derived CAR NK cells predominantly originate from CD7+CD56-CD34-HLA-DR-Lin- NK cell precursors in CB. Here, we demonstrate that stimulating the interleukin (IL)-15 receptor on these NK precursors enhances the production of CAR NK cells from CB cells. In CB CD56-CD34-HLA-DR-Lin- cells, the IL-15 receptor was exclusively expressed on CD7+ NK cell precursors. Using K562 feeder cells that express not only 4-1BB ligand and membrane-bound (mb) IL-21 but also mbIL-15 significantly increased the production of mature NK cells from the purified NK cell precursors or T cell-depleted CB cells. The in vitro and in vivo antitumor effects of CAR NK cells generated using K562 feeder cells that express mbIL-15 were comparable to those of CAR NK cells produced using K562 feeder cells that do not express mbIL-15. These results suggest that K562 feeder cells expressing 4-1BBL, mbIL-21, and mbIL-15 can increase the production of CAR NK cells from CB cells while maintaining their cytotoxic potential. This method could also be useful for expanding NK cells from CB for any type of adoptive NK cell therapy with or without CAR transduction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Osaka Research Center for Drug Discovery, Otsuka Pharmaceutical Company, Ltd., Minoh, Osaka, 562-0029, Japan.
- Department of Hematology and Oncology, The University of Osaka Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan.
- World Premier International Immunology Frontier Research Center, The University of Osaka, Suita, Osaka, 565-0871, Japan.
- Department of Clinical Laboratory and Biomedical Sciences, The University of Osaka Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
- Genome Information Research Center, Research Institute for Microbial Diseases, The University of Osaka, Suita, Osaka, 565-0871, Japan.
- Department of Hematology and Oncology, The University of Osaka Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan. hnaoki@bldon.med.osaka-u.ac.jp.
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Kogue, Y., Ikeda, S., Maehara, Y., Kawamoto, R., Suga, M., Kida, S., Shibata, K., Tsutsumi, K., Murakami, H., Mizuta, E., Mizutani, Y., Yamaguchi, Y., Okuzaki, D., & Hosen, N. (2025). CAR NK cell production from human cord blood NK progenitor cells is enhanced by stimulation of the IL-15 receptor. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-025-04191-0
Vancouver
Kogue Y, Ikeda S, Maehara Y, Kawamoto R, Suga M, Kida S, et al. CAR NK cell production from human cord blood NK progenitor cells is enhanced by stimulation of the IL-15 receptor. Cancer Immunology, Immunotherapy. 2025. doi:10.1007/s00262-025-04191-0
BibTeX
@article{Kogue2025,
author = {Kogue, Yosuke and Ikeda, Shunya and Maehara, Yuto and Kawamoto, Ryuhei and Suga, Makiko and Kida, Shuhei and Shibata, Kumi and Tsutsumi, Kazuhito and Murakami, Hiraku and Mizuta, Emiko and Mizutani, Yo and Yamaguchi, Yuta and Okuzaki, Daisuke and Hosen, Naoki},
title = {CAR NK cell production from human cord blood NK progenitor cells is enhanced by stimulation of the IL-15 receptor},
journal = {Cancer Immunology, Immunotherapy},
year = {2025},
doi = {10.1007/s00262-025-04191-0}
}
EUVIMED